Last reviewed · How we verify
Placebo gas for inhalation
Placebo gas for inhalation is a Small molecule drug developed by Washington University School of Medicine. It is currently FDA-approved for Research use as control comparator in clinical trials.
A placebo gas for inhalation produces no pharmacological effect and serves as a control comparator in clinical research.
A placebo gas for inhalation produces no pharmacological effect and serves as a control comparator in clinical research. Used for Research use as control comparator in clinical trials.
At a glance
| Generic name | Placebo gas for inhalation |
|---|---|
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo inhalation gases are inert formulations (typically air or nitrogen) used in randomized controlled trials to blind participants and researchers to treatment assignment. They allow for assessment of the true drug effect by controlling for placebo response, expectation effects, and natural disease progression. The gas itself has no active molecular mechanism.
Approved indications
- Research use as control comparator in clinical trials
Common side effects
Key clinical trials
- SMILE Trial - Imaging Sub-Study
- Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction. (PHASE3)
- N2O for Acute Suicidality and Depression in the ED (PHASE2)
- Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients (PHASE4)
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections (PHASE4)
- Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT) (NA)
- Antidepressant Effects of Nitrous Oxide (PHASE2)
- Nitrous Oxide as Treatment for Fibromyalgia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo gas for inhalation CI brief — competitive landscape report
- Placebo gas for inhalation updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI